HISTIOCYTIC SARCOMA
Clinical trials for HISTIOCYTIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC SARCOMA trials appear
Sign up with your email to follow new studies for HISTIOCYTIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat rare diseases: experimental drug targets faulty cell signals
Disease control Recruiting nowThis study is testing whether the drug cobimetinib can help control several rare disorders caused by overactive immune cells, particularly when standard treatments have failed. The trial will enroll 90 children and adults with conditions like Langerhans cell histiocytosis (LCH) a…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New pill aims to turn immune system against tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called Q702 for patients with advanced blood cancers and rare immune cell disorders that have not responded to standard treatments. The main goals are to find the safest dose and see what side effects occur. Researchers hope…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC